OT Pharma Fund VIII, LLC
Ot · adviser of record: OT Management, LLC · 2023 vintage
OT Pharma Fund VIII, LLC is a 2023 venture fund managed by Ot, with $2.4mm raised (Form D, amount sold). It reported $11.2mm in gross assets at year-end 2025, 4.68x its size, its highest reported value.
- Latest value held
- $11.2mm year-end 2025
- Peak
- $11.2mm year-end 2025
- Fund size
- $2.4mm Form D, amount sold
- Held vs. size
- 4.68x peak 4.68x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $11.2mm | 4.68x | +90% over 2 yrs |
| 2023 | $5.9mm | 2.46x | – |
Other funds from Ot
- OT EM Fintech Fund I, LLC 2022
- OT MBC Fund I, LLC 2022
- OT Dapper Fund I, LP 2021
- Zola Global Investors I, LLC 2021
- OT Asia Fintech Fund I, LLC 2021
- OT Bioag Fund III, LLC 2021
- Zola Ventures Fund I, LLC 2021
- QLT Holdings, LLC 2021
- OT Pharma Fund VII, LLC 2021
- Otgc Fintech Fund I, LLC 2021
- OT Hsa Fund I, LLC 2021
- OT Proptech Fund I, LLC 2021
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-9215391930. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.